[HTML][HTML] Selective inhibition of tumor cell associated Vacuolar-ATPase 'a2'isoform overcomes cisplatin resistance in ovarian cancer cells
A Kulshrestha, GK Katara, J Ginter, S Pamarthy… - Molecular …, 2016 - Elsevier
Abstract Development of resistance to platinum compounds significantly hinders successful
ovarian cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell …
ovarian cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell …
Selective inhibition of tumor cell associated Vacuolar-ATPase'a2'isoform overcomes cisplatin resistance in ovarian cancer cells
A Kulshrestha, GK Katara, J Ginter… - Molecular …, 2016 - pubmed.ncbi.nlm.nih.gov
Development of resistance to platinum compounds significantly hinders successful ovarian
cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell membranes is …
cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell membranes is …
Selective inhibition of tumor cell associated Vacuolar-ATPase'a2'isoform overcomes cisplatin resistance in ovarian cancer cells.
A Kulshrestha, GK Katara, J Ginter, S Pamarthy… - Molecular …, 2016 - europepmc.org
Abstract Development of resistance to platinum compounds significantly hinders successful
ovarian cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell …
ovarian cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell …
Selective inhibition of tumor cell associated Vacuolar-ATPase 'a2'isoform overcomes cisplatin resistance in ovarian cancer cells
A Kulshrestha, GK Katara, J Ginter, S Pamarthy… - Molecular …, 2016 - infona.pl
Development of resistance to platinum compounds significantly hinders successful ovarian
cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell membranes is …
cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell membranes is …
[HTML][HTML] Selective inhibition of tumor cell associated Vacuolar‐ATPase 'a2'isoform overcomes cisplatin resistance in ovarian cancer cells
A Kulshrestha, GK Katara, J Ginter, S Pamarthy… - Molecular …, 2016 - ncbi.nlm.nih.gov
Abstract Development of resistance to platinum compounds significantly hinders successful
ovarian cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell …
ovarian cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell …
Selective inhibition of tumor cell associated Vacuolar‐ATPase 'a2'isoform overcomes cisplatin resistance in ovarian cancer cells
A Kulshrestha, GK Katara, J Ginter… - Molecular …, 2016 - search.proquest.com
Abstract Development of resistance to platinum compounds significantly hinders successful
ovarian cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell …
ovarian cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell …
Selective inhibition of tumor cell associated Vacuolar‐ATPase 'a2'isoform overcomes cisplatin resistance in ovarian cancer cells
A Kulshrestha, GK Katara, J Ginter… - Molecular …, 2016 - Wiley Online Library
Development of resistance to platinum compounds significantly hinders successful ovarian
cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell membranes is …
cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell membranes is …
Selective inhibition of tumor cell associated Vacuolar-ATPase'a2'isoform overcomes cisplatin resistance in ovarian cancer cells.
A Kulshrestha, GK Katara, J Ginter, S Pamarthy… - Molecular …, 2016 - europepmc.org
Abstract Development of resistance to platinum compounds significantly hinders successful
ovarian cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell …
ovarian cancer (OVCA) treatment. In tumor cells, dysregulated pH gradient across cell …